Serotonin-induced platelet intracellular Ca2+ responses in untreated depressed patients and imipramine responders in remission

Biological Psychiatry

Volumn 45, Issue 8, 1999, Pages 1042-1048

  Tomiyoshi, Rika ^a   Kamei, Kenji ^a   Muraoka, Shinichiro ^a   Muneoka, Katsumasa ^a   Takigawa, Morikuni ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Ca2+; Depression; Imipramine; Platelet; Remission; Serotonin

Indexed keywords

CALCIUM ION; IMIPRAMINE; SEROTONIN;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REMISSION; THROMBOCYTE ACTIVATION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD PLATELETS; CALCIUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMIPRAMINE; INTRACELLULAR MEMBRANES; MALE; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEROTONIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0033560703     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00171-1     Document Type: Article

References (45)

1. 2 binding sites in the frontal cortex of suicide victims and control subjects . Am J Psychiatry. 146:1989;730-736.
2. Åberg-Wistedt A., Ross S.B., Jostell K., Sjöquist B. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression II. Biochemical findings. Acta Psychiatr Scand. 66:1982;66-82.
3. Ågren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid I. General patterns . Psychiatry Res. 3:1980;211-223.
4. Åsberg M., Bertilsson L., Mårtensson B., Scalia-Tomba G., Thorén P., Träskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand. 69:1984;201-219.
5. Asnis G.M., Eisenberg J., vanPraag H.M., Lemus C.Z., Friedman J.M.H., Miller A.H. The neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatry. 24:1988;117-120.
6. Biegon A., Weizman A., Karp L., Ram A., Tiano S., Wolff M. Serotonin 5-HT2 receptor binding on blood platelets - A peripheral marker for depression? Life Sci. 41:1987;2485-2492.
7. Bothwell R.A., Eccleston D., Marshall E. Platelet intracellular calcium in patients with recurrent affective disorders. Psychopharmacology (Berl). 114:1994;375-381.
8. Butler J., Leonard B.E. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol. 3:1988;343-347.
9. 2+ levels in neuronal culture. Eur J Pharmacol. 219:1992;53-57.
10. Charney D.S., Menkes D.B., Heninger G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment Implications for the etiology and therapy of depression . Arch Gen Psychiatry. 38:1991;1160-1180.
11. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry. 46:1989;587-599.
12. Cowen P.J., Charig E.M. Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry. 44:1987;958-966.
13. Cowen P.J., Geaney D.P., Schächter M., Green A.R., Elliott J.M. Desipramine treatment in normal subjects. Arch Gen Psychiatry. 43:1986;61-67.
14. Cowen P.J., Charig E.M., Fraser S., Elliott J.M. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord. 13:1987;45-50.
15. Deakin J.F.W., Pennell I., Upadhyaya A.J., Lofthouse R. A neuroendocrine study of 5HT function in depression Evidence for biological mechanisms of endogenous and psychosocial causation . Psychopharmacology (Berl). 101:1990;85-92.
16. Dubovsky S.L., Christiano J., Daniell L.C., Franks R.D., Murphy J., Adler L., et al. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry. 46:1989;632-638.
17. Dubovsky S.L., Lee C., Christiano J., Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry. 29:1991;441-450.
18. Dubovsky S.L., Murphy J., Thomas M., Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 149:1992;118-120.
19. 2 receptor stimulation in platelets of depressed patients. Biol Psychiatry. 34:1993;565-568.
20. Eckert A., Gann H., Riemann D., Aldenhoff J., Müller W.E. Platelet and lymphocyte free intracellular calcium in affective disorders. Eur Arch Psychiatry Clin Neurosci. 243:1994;235-239.
21. Endicott J., Cohen J., Nee J., Fleiss J., Sarantakos S. Hamilton depression rating scale extracted from regular and change versions of the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 38:1981;98-103.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
23. Healy D., Carney P.A., Leonard B.E. Monoamine-related markers of depression Changes following treatment . J Psychiatr Res. 17:1983;251-260.
24. Healy D., Carney P.A., O'Halloran A., Leonard B.E. Peripheral adrenoceptors and serotonin receptors in depression Changes associated with response to treatment with trazodone or amitriptyline . J Affect Disord. 9:1985;285-296.
25. Heninger G.R., Charney D.S. Mechanism of action of antidepressant treatment Imprications for the etiology and treatment of depressive disorders . Meltzer H.Y. Psychopharmacology The third genertion of progress . 1987;535-544 Raven press, New York.
26. 2+ response in human platelets. Life Sci. 48:1991;2405-2412.
27. 2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry. 30:1991;310-312.
28. Kusumi I., Koyama T., Yamashita I. Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology (Berl). 113:1994;322-327.
29. 1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 46:1990;1271-1277.
30. Maas J.W., Kocsis J.H., Bowden C.L., Davis J.M., Redmond D.E., Hanin I., et al. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med. 12:1982;37-43.
31. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
32. Meltzer H.Y., Umberkoman-Wiita B., Robertson A., Tricou G.J., Lowy M., Perline R. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders I. Enhanced response in depression and mania. Arch Gen Psychiatry. 41:1984;366-374.
33. Meltzer H.Y., Lowy M.T. The serotonin hypothesis of depression. Meltzer H.Y. Psychopharmacology The third generation of progress . 1987;513-526 Raven press, New York.
34. Mikuni M., Kagaya A., Takahashi K., Meltzer H.Y. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology (Berl). 106:1992;311-314.
35. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
36. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
37. Okamoto Y., Kagaya A., Shinno H., Motohashi N., Yamawaki S. Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci. 56:1995;327-332.
38. Roy A., Pickar D., Linnoila M., Doran A.R., Ninan P., Paul S.M. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res. 15:1985;281-292.
39. Schildkraut J.J. The catecholamine hypothesis of affective disorders A review of supporting evidence . Am J Psychiatry. 122:1965;509-517.
40. Siever L.J., Murphy D.L., Slater S., de la Vega E., Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls An evaluation of central serotonergic responsivity in depression . Life Sci. 34:1984;1029-1039.
41. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. i:1983;214-216.
42. Sugrue M.F. Current concepts on the mechanisms of action of antidepressant drugs. Pharmacol Ther. 13:1981;219-247.
43. Vestergaard P., Sørensen T., Hoppe E., Rafaelsen O.J., Yates C.M., Nicolaou N. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand. 58:1978;88-96.
44. Weizman A., Mark M., Gil-Ad I., Tyano S., Laron Z. Plasma cortisol, prolactin, growth hormone, and immunoreactive β-endorphin response to fenfluramine challenge in depressed patients. Clin Neuropharmacol. 11:1988;250-256.
45. Westenberg H.G.M., Verhoeven W.M.A. CSF monoamine metabolites in patients and controls Support for a bimodal distribution in major affective disorders . Acta Psychiatr Scand. 78:1988;541-549.